US pharmaceutical giant Merck is scrapping a planned £1bn expansion of its UK operations, saying the government is not investing enough in the sector. The multi-national business, known as MSD in Europe, said it would move its life sciences research to the US and cut UK jobs, blaming successive gov»»»

Merck, the U.S. pharmaceutical group, has dropped plans to build a $1.4-billion research centre in Britain, blaming the country's "lack of investment" in the sector and its drugs prices. The company said in a statement it would not go through with the construction, which had been slated for the Kin»»»